List of Excipients in API TIGECYCLINE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing TIGECYCLINE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | TYGACIL | tigecycline | 0008-4990 | HYDROCHLORIC ACID | |
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | TYGACIL | tigecycline | 0008-4990 | LACTOSE MONOHYDRATE | |
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | TYGACIL | tigecycline | 0008-4990 | SODIUM HYDROXIDE | |
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | TYGACIL | tigecycline | 0008-4994 | HYDROCHLORIC ACID | |
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | TYGACIL | tigecycline | 0008-4994 | LACTOSE MONOHYDRATE | |
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | TYGACIL | tigecycline | 0008-4994 | SODIUM HYDROXIDE | |
| Accord Healthcare Inc | TIGECYCLINE | tigecycline | 16729-364 | HYDROCHLORIC ACID | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing TIGECYCLINE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Sandoz Inc | tigecycline | 0781-3481 | HYDROCHLORIC ACID |
| Sandoz Inc | tigecycline | 0781-3481 | LACTOSE MONOHYDRATE |
| Sandoz Inc | tigecycline | 0781-3481 | SODIUM HYDROXIDE |
| AuroMedics Pharma LLC | tigecycline | 55150-228 | HYDROCHLORIC ACID |
| AuroMedics Pharma LLC | tigecycline | 55150-228 | LACTOSE MONOHYDRATE |
| AuroMedics Pharma LLC | tigecycline | 55150-228 | SODIUM HYDROXIDE |
| Apotex Corp | tigecycline | 60505-6098 | HYDROCHLORIC ACID |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for TIGECYCLINE
Excipient focus: ARGININE
TIGECYCLINE drug variants containing ARGININE
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | tigecycline | 63323-960 |
| >Company | >Ingredient | >NDC |
TIGECYCLINE drug variants not containing ARGININE
Excipient focus: HYDROCHLORIC ACID
TIGECYCLINE drug variants containing HYDROCHLORIC ACID
TIGECYCLINE drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | tigecycline | 63323-960 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
TIGECYCLINE drug variants containing LACTOSE MONOHYDRATE
TIGECYCLINE drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | tigecycline | 16729-364 |
| Fresenius Kabi USA LLC | tigecycline | 63323-960 |
| Amneal Pharmaceuticals LLC | tigecycline | 70121-1647 |
| >Company | >Ingredient | >NDC |
Excipient focus: MALTOSE
TIGECYCLINE drug variants containing MALTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | tigecycline | 16729-364 |
| >Company | >Ingredient | >NDC |
TIGECYCLINE drug variants not containing MALTOSE
Excipient focus: SODIUM HYDROXIDE
TIGECYCLINE drug variants containing SODIUM HYDROXIDE
TIGECYCLINE drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | tigecycline | 63323-960 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
